Home › Heart Attack › Maryland
Heart Attack clinical trials in Maryland
3 studies for Heart Attack are looking for participants at sites in Maryland.
Cities in Maryland
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- University of Maryland, Baltimore
- Sinai Ct for Throm Res and Drug Dev, Baltimore
- Johns Hopkins Univ School of Med, Baltimore
- and 3 more
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 4, 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Ascension Saint Agnes Heart Care, Baltimore
- Johns Hopkins Hospital, Baltimore
- Metropolitan Cardiovascular Consultants LLC, Beltsville
- and 5 more
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012Focused Orticumab Research for Treating Inflammation in Coronary Arteries
- Abcentra Investigational Site, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jan 27, 2026 · NCT06927739From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.